|
Volumn 176, Issue 10, 2016, Pages 1554-1555
|
Adverse effects from counterfeit alprazolam tablets
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALCOHOL;
ALPRAZOLAM;
ASPARTATE AMINOTRANSFERASE;
CREATINE KINASE;
ETIZOLAM;
FENTANYL;
TROPONIN;
ANXIOLYTIC AGENT;
COUNTERFEIT DRUG;
ACUTE KIDNEY FAILURE;
ADOLESCENT;
ADULT;
CENTRAL NERVOUS SYSTEM DEPRESSION;
CLINICAL ARTICLE;
DRUG BLOOD LEVEL;
FEMALE;
HEART FAILURE;
HUMAN;
INFANT;
LABORATORY TEST;
LAW ENFORCEMENT;
LETTER;
LEUKOCYTE COUNT;
LEUKOCYTOSIS;
MALE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RHABDOMYOLYSIS;
SEDATION;
SIDE EFFECT;
TABLET;
YOUNG ADULT;
CASE REPORT;
CHEMICALLY INDUCED;
EMERGENCY;
HEART MUSCLE ISCHEMIA;
PARESTHESIA;
ACUTE KIDNEY INJURY;
ADULT;
ALPRAZOLAM;
ANTI-ANXIETY AGENTS;
COUNTERFEIT DRUGS;
EMERGENCIES;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL ISCHEMIA;
PARESTHESIA;
RHABDOMYOLYSIS;
TABLETS;
|
EID: 84997481973
PISSN: 21686106
EISSN: None
Source Type: Journal
DOI: 10.1001/jamainternmed.2016.4306 Document Type: Letter |
Times cited : (73)
|
References (5)
|